Showing results (121-130 of 646) with videos related to
Sort By:
Pageof 65
Leukemia & Lymphoma|June 10, 2010
Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactionsEran Ben-Arye, Samuel Attias, Tamar Tadmor, et al.Leukemia & Lymphoma|November 23, 2020
Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyondSean Harrop, Aaron Polliack, Constantine S TamHaematologica|July 15, 2003
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenanceYossi Cohen, Philippe Solal-Céligny, Aaron PolliackLeukemia Research|November 21, 2018
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biologyAlina Klein, Aaron Polliack, Anat Gafter-GviliHematological Oncology|June 5, 2018
Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcomeAlina Klein, Aaron Polliack, Anat Gafter-GviliHematological Oncology|October 1, 2021
A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agentsStefano Molica, John F Seymour, Aaron PolliackLeukemia Research|June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemiaTamar Tadmor, Ilana Levy, Yair Herishanu, et al.Expert Review of Molecular Diagnostics|May 15, 2010
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosisArun Balakumaran, Pamela Gehron Robey, Neal Fedarko, et al.Mayo Clinic Proceedings|March 3, 2010
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinicIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.Blood|June 21, 2013
Pursuing the curative blueprint for early myelomaMark Roschewski, Neha Korde, S Peter Wu, et al.Pageof 65